FDA approves CATALYST trial of Abbott’s Amplatzer Amulet for stroke
The CATALYST clinical trial will evaluate the effectiveness of the Abbott Amplatzer Amulet compared to NOACs as an…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
04 Feb 20
The CATALYST clinical trial will evaluate the effectiveness of the Abbott Amplatzer Amulet compared to NOACs as an…
Exscientia CEO Andrew Hopkins has described the OCD medication reaching human trials as a "key milestone" in AI…
23 Jan 20
The PREDICT trial is designed to evaluate the efficacy and safety of SUBA-Itraconazole capsules, in combination with docetaxel…
Chemotherapy is used to treat solid tumours, which account for more than 40% of cancers
A number of health sector experts believe PrEP can reduce the likelihood of getting HIV by 99% when…
07 Jan 20
BAVENCIO was approved by the US Food and Drug Administration (FDA), for the treatment of patients with locally…
19 Dec 19
BLISS-LN clinical trial evaluated the safety and efficacy of Benlysta in the enrolled 448 patients with active lupus…
19 Dec 19
TRIUMPH clinical trial is expected to enrol approximately 2,850 patients from multiple sites across the US, Europe and…
12 Dec 19
LOXO-292 is a highly selective and potent, oral investigational medicine, which is currently under clinical development for the…
The new drug differs from many established acute migraine treatments by lowering blood pressure, rather than raising it